Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis

Mycobacterium tuberculosis (Mtb) represents a major burden to global health, and refined vaccines are needed. Replication-deficient lymphocytic choriomeningitis virus (rLCMV)-based vaccine vectors against cytomegalovirus have proven safe for human use and elicited robust T cell responses in a large...

Descripción completa

Detalles Bibliográficos
Autores principales: Belnoue, Elodie, Vogelzang, Alexis, Nieuwenhuizen, Natalie E., Krzyzaniak, Magdalena A., Darbre, Stephanie, Kreutzfeldt, Mario, Wagner, Ingrid, Merkler, Doron, Lambert, Paul-Henri, Kaufmann, Stefan H. E., Siegrist, Claire-Anne, Pinschewer, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911050/
https://www.ncbi.nlm.nih.gov/pubmed/35269842
http://dx.doi.org/10.3390/ijms23052700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911050/
https://www.ncbi.nlm.nih.gov/pubmed/35269842
http://dx.doi.org/10.3390/ijms23052700

Ejemplares similares